Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Continuous Glucose Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global continuous glucose monitoring systems market reached a value of US$ 5.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.56 Billion by 2027, exhibiting a growth rate (CAGR) of 9.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global continuous glucose monitoring systems market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, demographics and end user.

Breakup by Component:

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Sensors
  • Transmitters and Receivers 
  • Integrated Insulin Pumps
     

Breakup by Demographics:

  • Child Population (≤14 years)
  • Adult Population (>14 years)
     

Breakup by End User:

  • Clinics and Diagnostics Centers
  • ICUs
  • Home Healthcare
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Component, Demographics, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Continuous Glucose Monitoring Systems Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Component
    6.1    Sensors 
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Transmitters and Receivers 
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Integrated Insulin Pumps
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Demographics
    7.1    Child Population (≤14 years)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Adult Population (>14 years)
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by End User
    8.1    Clinics and Diagnostics Centers
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    ICUs
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Home Healthcare
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    A. Menarini Diagnostics S.r.l.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Abbott Laboratories
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    DexCom Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    F. Hoffmann-La Roche AG
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    Glysens Incorporated
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    LifeScan Inc. (Johnson & Johnson)
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 SWOT Analysis
        14.3.7    Medtronic PLC
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Medtrum Technologies Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Nemaura Medical Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    Novo Nordisk A/S
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Senseonics Holdings Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
        14.3.12    Waveform Technologies Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio

List of Figures

Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2021
Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2021
Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2021
Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2021
Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (≤14 years)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (≤14 years)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2021
Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million US$), 2022-2027
Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global continuous glucose monitoring systems market was valued at US$ 5.46 Billion in 2021.

 

We expect the global continuous glucose monitoring systems market to exhibit a CAGR of 9.50% during 2022-2027.

The sudden outbreak of the COVID-19 pandemic has led to the growing demand for remote monitoring devices, such as continuous glucose monitoring systems to continuously monitor the coronavirus-infected patients with diabetes. 

The rising adoption of continuous glucose monitoring systems for measuring glucose and insulin level in the body, as they are non-invasive and provide real-time information, is primarily driving the global continuous glucose monitoring systems market.

Based on the component, the global continuous glucose monitoring systems market can be segmented into sensors, transmitters and receivers, and integrated insulin pumps. Among these, sensors hold the majority of the total market share.

Based on the demographics, the global continuous glucose monitoring systems market has been divided into child population (≤14 years) and adult population (>14 years), where adult population (>14 years) currently exhibits a clear dominance in the market.

 

Based on the end user, the global continuous glucose monitoring systems market can be categorized into clinics and diagnostics centers, ICUs, and home healthcare. Currently, home healthcare accounts for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global continuous glucose monitoring systems market include A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc., and Waveform Technologies Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4